Ex-4 inhibits mTOR, an autophagy inhibitor in tumor cells, by downregulating Akt and simultaneously activating AMPK, subsequently attenuating the phosphorylation of its major downstream targets, eukaryotic translation initiation factor 4e binding protein 1(4E-BP1) and ribosomal s6 kinase 1(S6K1)
Those with existing cardiovascular conditions should be especially cautious and consult a provider before beginning treatment
Originally developed to help manage blood sugar levels in people with type 2 diabetes, semaglutide has gained attention for its remarkable impact on weight loss when used at higher doses
Skin aging and oxidative stress
For obesity, Semaglutide is indicated for individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher alongside a weight-related health condition
09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice